Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
Signifor (pasireotide)
i
Other names:
SOM230
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Recordati
Drug class:
SSTR agonist
Related drugs:
‹
octreotide (10)
lanreotide prolonged-release subcutaneous (2)
DG3173 (1)
octreotide subcutaneous depot (0)
octreotide extended release (0)
vapreotide (0)
pasireotide long acting release (0)
VMT-𝛼-NET (0)
Debio 4126 (0)
octreotide acetate (0)
octreotide acetate solution for injection (0)
MTD201 (0)
octreotide (10)
lanreotide prolonged-release subcutaneous (2)
DG3173 (1)
octreotide subcutaneous depot (0)
octreotide extended release (0)
vapreotide (0)
pasireotide long acting release (0)
VMT-𝛼-NET (0)
Debio 4126 (0)
octreotide acetate (0)
octreotide acetate solution for injection (0)
MTD201 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
BRAF wild-type + NRAS wild-type
Melanoma
BRAF wild-type + NRAS wild-type
Melanoma
pasireotide
Sensitive: C3 – Early Trials
pasireotide
Sensitive
:
C3
pasireotide
Sensitive: C3 – Early Trials
pasireotide
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login